Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SCGF-b | 67.5 | 36 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SCGF-b | 72.0 | 61 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SCGF-b | 72.0 | 73 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | SCGF-b | 64.0 | 34 | |
N2586 | EO1428 | 1.0 | uM | 1 | SCGF-b | 79.0 | 68 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 78.0 | 51 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 83.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 64.0 | 44 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 90.5 | 46 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 58.0 | 47 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 67.0 | 57 | |
RA2159 | PI103 | 0.1 | uM | 1 | SCGF-b | 72.0 | 45 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 67.5 | 56 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 78.0 | 37 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 82.5 | 56 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 74.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 70.0 | 57 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | SCGF-b | 63.0 | 46 | |
N2586 | PI103 | 0.1 | uM | 1 | SCGF-b | 77.0 | 43 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | SCGF-b | 76.0 | 58 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | SCGF-b | 70.5 | 58 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | SCGF-b | 74.5 | 52 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | SCGF-b | 71.0 | 46 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | SCGF-b | 64.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | SCGF-b | 67.5 | 48 |